SCEMBLIX

Formula & Concentration

SCEMBLIX – asciminib 40 mg tablet

Manufacturer

Novartis Pharmaceuticals Corp

Indications

chronic phase Philadelphia chromosome (+) CML; chronic phase Philadelphia chromosome (+) CML with T315I

Product Options

Package Size

NDC #

Presentation

40 MG

00078-1098-20

TABLET

Shelf Life and Storage

Controlled Room Temp (20-25°C)